Climate-related hazards are poised to significantly disrupt the chemicals industry, according to a new report, and will drive structural changes to industry production. Read the C&I article
Researchers are developing a multi-organ in vitro Human-on-a-Chip system to investigate the impact of opiate overdoses on the brain stem, kidneys, heart, skeletal muscles and liver. The research will also evaluate the acute and chronic effects of overdose treatments, such as naloxone (Narcan). Read the C&I article
Dragonfly and cicada wings – along with gecko feet – are known to have bactericidal properties. Now, researchers in Japan report that this activity depends on the ability of the bacteria to move toward and adhere to these surfaces.
US biotech Verve Therapeutics has for the first time shown that base editing can be used to turn off a gene in the liver in non-human primates. The trial was part of the company’s programme to create a ‘one-and-done’ gene editing treatment for lowering cholesterol. Read the article in C&I magazine.
A derivative of a natural flavonoid compound has reversed memory loss in a mouse genetically modified to mirror inherited Alzheimer’s disease (AD). Read the C&I article.
The Covid-19 pandemic has caught healthcare systems, politicians and many virologists on the hop. Yet some scientists are now warning about a newer threat. Read more in C&I Magazine.
Fine tuning a familiar organic conducting polymer could help to improve communication between biomedical hardware and human tissues, researchers have discovered. Read more in C&I Magazine.
Scientists in the US have concluded that agricultural sulfur – and not coal-fired power stations – is now the most important source of the element to the environment, as large quantities are being added to farmland as fertilisers and pesticides (Nature Geoscience, doi: 10.1038/s41561-020-0620-3). Read the C&I article.
South Africa-based pharmaceutical company Aspen has announced a proposed price reduction of up to 73% for critical cancer medicines after the European Commission raised concerns over possible overpricing. Read the article in C&I.
Researchers have discovered how to activate brown fat in humans, which may pave the way to new treatments for Type 2 diabetes and obesity.